RxGen and Santaris Pharma Use LNA Technology to Suppress a MicroRNA in Liver of a Non-Human Primate and Safely Lower Serum Cholesterol Hamden, CT and Hørsholm, Denmark --- Business Wire March 27, 2008 --- In a study published in the journal Nature today, Santaris Pharma and RxGen, Inc., a specialty pharma services company demonstrated that locked ...
Therapeutic Development Through Innovative Research
Monthly Archives: March 2009
RxGen Hosts First Annual “microRNA in Human Disease” Meeting with Santaris Pharma
HAMDEN, CT March 15, 2009 – RxGen and Santaris Pharma announce the recent conclusion of a highly successful three day scientific meeting in St. Kitts, West Indies. The meeting was designed to engage leading scientists and postdoctoral students working in all aspects of microRNA research in a symposium addressing microRNA biology and its involvement in ...
